Adam Kop­pel and Jeff Schwartz are done rais­ing cap­i­tal. Now they have $720M to do some se­ri­ous deals at Bain

When Adam Kop­pel looped back to Bain Cap­i­tal last sum­mer, where he had al­ready wired him­self in­to the health­care fi­nance field, he im­me­di­ate­ly paired back up with long­time part­ner-in-arms, Jeff Schwartz, and be­gan to cre­ate a new life sci­ences fund with enough cap­i­tal on hand to make a deep im­pact on the biotechs they would choose to back.

To­day marks the of­fi­cial end of the fundrais­ing pe­ri­od and the be­gin­ning of a 3- to 5-year stint spend­ing all of their time in­vest­ing the $720 mil­lion the two have raised; $600 mil­lion of that from ex­ter­nal sources with the oth­er $120 mil­lion from Bain part­ners.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.